Target ALS today announced the launch of its newly redesigned website, a major step forward in its mission to democratize ALS research and accelerate the development of effective treatments for people ...

Neurodegenerative diseases such as Alzheimer's, Parkinson's, Huntington's, and amyotrophic lateral sclerosis (ALS) affect millions of people worldwide, yet treatments remain largely limited to symptom ...

The deputy mayor of Charlottetown from Caribou Island, N.S., went into the studio with producer David Rashed in November 2024 and recorded Gail’s Guitar, not as a goodbye to her mom but about the in ...

By Vijay Kumar Malesu Even at relatively low pollution levels, chronic exposure to fine particles and nitrogen dioxide was ...

According to Mayo Clinic, stem cells are a special type of cell that have two important properties that make more cells like ...

PRESS RELEASE AB SCIENCE RECEIVES JAPANESE PATENT PROTECTION FOR THE USE OF MASITINIB IN PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS (MS) UNTIL 2041 THIS IS THE FIRST COUNTRY DELIVERING THE MS PATENT ...

A study suggests overactive VCP may contribute to ALS nerve damage by disrupting nuclear pore proteins in genetic ALS.

Health groups praised many of the provisions in the joint House-Senate bill that would fund the HHS and several other agencies for fiscal year 2026.

For more than 60 years, this blank slate approach has been the Food and Drug Administration’s gold standard — and for good ...

Patent protection extended through 2043Alzheimer's proof-of-concept study completedClinical and Biomarker Outcomes Expected ...

Many people's worst nightmare is being diagnosed with a terminal illness. It happens when you least expect it, and suddenly, ...

Neurodegenerative diseases such as Alzheimer's, Parkinson's, Huntington's, and amyotrophic lateral sclerosis (ALS) affect millions of people worldwide, yet treatments remain largely limited to symptom ...